Clinical trials
5 active studies led by Regend Therapeutics, of 11 in all
Source: ClinicalTrials.gov, Studies with Regend Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 4Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Regend Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Regend Therapeutics
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Regend Therapeutics leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Regend Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Regend Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Regend Therapeutics is in.
From our blog
Stories on the topics Regend Therapeutics works in.
Ambulance Services: The First Link in Emergency Care
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read
Air Ambulances: Life Support at Altitude
Road crashes kill about 1.16 million people a year, and more than half of deaths in poorer countries come…
Read
Airway Management Devices: Critical Tools in Emergencies
Keeping the airway open is the first step in saving a life. More than half of deaths in low- and…
Read